Background illustration for clinical trials search

Paid Clinical Trials Boulder

Discover 1,546 paid clinical trials in Boulder, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

for
Hematologic Malignancies, Waldenstroms Macroglobulinaemia,
Location: Denver CO, Springdale AR, Dallas TX, Spokane WA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT04728893

Phase 2, Recruiting

A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

for
Relapsed and/or Refractory Multiple Myeloma
Location: Denver CO, Duarte CA, Stanford CA, San Francisco CA,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06153251

Phase 1, Recruiting

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: Denver CO, Omaha NE, Oklahoma City OK, Kansas City KS,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06001788

Phase 1, Recruiting

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

for
Metastatic Uveal Melanoma, Cutaneous Melanoma,
Location: Denver CO, Los Angeles CA, Houston TX, Nashville TN,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT03947385

Phase 1, Phase 2, Recruiting

Study of APVO436 in Patients With AML or MDS

for
AML, MDS
Location: Denver CO, Salt Lake City UT, Westwood KS, Dallas TX,
Sponsor: Aptevo Research and Development LLC

Sex: All

Age: 18+

Code: NCT03647800

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

for
Neoplasms
Location: Denver CO, Aurora CO, Salt Lake City UT, Wichita KS,
Sponsor: Celgene

Sex: All

Age: 0+

Code: NCT03435796

Phase 2, Phase 3, Recruiting

APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML

for
Acute Myeloid Leukemia (AML)
Location: Denver CO, Fairway KS, Dallas TX, Houston TX,
Sponsor: Aptevo Therapeutics

Sex: All

Age: 18+

Code: NCT06634394

Phase 1, Recruiting

DALY II USA/ MB-CART2019.1 for DLBCL

for
Refractory Diffuse Large B Cell Lymphoma (DLBCL),
Location: Denver CO, Westwood KS, Phoenix AZ, Gilbert AZ,
Sponsor: Miltenyi Biomedicine GmbH

Sex: All

Age: 18+

Code: NCT04792489

Phase 2, Recruiting

CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)

for
AML, Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
Location: Denver CO, Sacramento CA, Houston TX, Seattle WA,
Sponsor: CERo Therapeutics Holdings, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06834282

Phase 1, Recruiting

Complex Adult Deformity Surgery (CADS)

for
Adult Spinal Deformity, Scoliosis, Kyphosis, Sagittal Imbalance
Location: Denver CO, Kansas City KS, Dallas TX, Shreveport LA,
Sponsor: International Spine Study Group Foundation

Sex: All

Age: 18+

Code: NCT04194138

Recruiting

Radiographic and Clinical Evaluation of Surgical Treatment for Cervical Deformity: A Multi-Center Study 2.0

for
Cervical Deformity
Location: Denver CO, Kansas City KS, Dallas TX, La Jolla CA,
Sponsor: International Spine Study Group Foundation

Sex: All

Age: 18+

Code: NCT04194996

Recruiting

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

for
Hematopoietic Cell Transplantation Recipient, Leukemia,
Location: Denver CO, Aurora CO, Albuquerque NM, Salt Lake City UT,
Sponsor: Children's Oncology Group

Sex: All

Age: 0+

Code: NCT00736749

Recruiting

QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry

for
Acute Kidney Injury, Acute Kidney Injury Due to Sepsis
Location: Denver CO, Fort Worth TX, Dallas TX, Houston TX,
Sponsor: SeaStar Medical

Sex: All

Age: 0 - 22

Code: NCT06517810

Recruiting

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Denver CO, Aurora CO, Albuquerque NM, Salt Lake City UT,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT06401330

Phase 3, Recruiting

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for
Rhabdomyosarcoma
Location: Denver CO, Aurora CO, Salt Lake City UT, Wichita KS,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT07466316

Phase 3, Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: Denver CO, Aurora CO, Albuquerque NM, Salt Lake City UT,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase 3, Recruiting

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

for
Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia
Location: Denver CO, Albuquerque NM, Des Moines IA, Fargo ND,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT07022678

Phase 3, Recruiting

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Denver CO, Aurora CO, Albuquerque NM, Salt Lake City UT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 30

Code: NCT04546399

Phase 2, Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

for
Recurrent Langerhans Cell Histiocytosis,
Location: Denver CO, Aurora CO, Salt Lake City UT, Omaha NE,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 22

Code: NCT05828069

Phase 2, Recruiting

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Denver CO, Aurora CO, Albuquerque NM, Salt Lake City UT,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT03959085

Phase 3, Recruiting